Study points to unusual kidney fats in cats with CKD risk

A new University of Nottingham study is pointing veterinary medicine toward an unusual suspect in feline chronic kidney disease: fats that seem to build up in cat kidneys in ways not seen in dogs. The work, published February 23, 2026, in Frontiers in Veterinary Science, found that domestic cats accumulate rare modified triglycerides within renal cells, including lipid species with ether linkages and branched structures. The university’s March 4, 2026, announcement framed the finding as a possible clue to why domestic cats are especially vulnerable to CKD. (frontiersin.org)

That vulnerability has long been recognized, even if its root causes remain unsettled. International feline CKD guidance describes the disease as one of the most commonly diagnosed conditions in older cats, and NC State researchers recently summarized estimates suggesting 30% to 50% of cats over age 10 are affected. Earlier Nottingham work had also shown that the “normal” feline kidney is unusual compared with other species because lipid droplets are physiologically visible in proximal tubular epithelium, giving the organ its characteristic yellow tinge. (pubmed.ncbi.nlm.nih.gov)

The new lipidomics study appears to build on that observation by asking not just whether lipid droplets are present, but what they are made of. According to the paper and the university release, the unusual lipid pattern was present in domestic cats, absent in dogs, and only occasional in Scottish wildcats used as a comparator. That design matters because it helps separate a strictly feline signal from one driven only by shared domestic environments or processed diets, though the study does not prove causation. (frontiersin.org)

The authors’ interpretation is cautious. Nottingham said the lipid buildup may be an early marker of chronic renal stress and could contribute to tissue injury over time, but the study stops short of showing that these fats directly cause CKD. In the university release, lead researchers Dr. Rebecca Brociek and Professor David Gardner said the next step is figuring out why these lipids accumulate and whether that process can be modified, potentially through diet or supplementation. (nottingham.ac.uk)

The broader CKD research landscape gives this finding extra context. A separate 2025 multi-omics study from Nestlé Purina Research and collaborators at Texas A&M, Ohio State, Penn, and Kansas State linked spontaneous feline CKD to altered renal metabolism and distinct serum metabolomic changes. Reporting from the ACVIM Forum also described parallel shifts in fecal metabolites in 108 cats across CKD stages, with many of the differences involving fats and related compounds, plus signals tied to gut lining effects and inflammation. In that work, N1-methyl-2-pyridone-5-carboxamide, or 2PY, emerged as the strongest fecal marker associated with CKD; earlier serum data had already suggested 2PY rises even in early disease and increases with severity, and the fecal analysis found it also tracked with serum creatinine. Cats with CKD also had higher branched short-chain fatty acids, a finding that may reflect altered gut microbial activity. Taken together, the field is increasingly circling lipid handling, metabolism, inflammation, and the gut-kidney axis as part of the feline CKD story, rather than viewing the disease only through the lens of late-stage azotemia and fibrosis. (pubmed.ncbi.nlm.nih.gov)

Emerging transcriptomic work adds another layer. In a recent secondary analysis of public feline renal cortex RNA-seq data, investigators examined genes involved in hypoxia response, iron handling, and lipid oxygenation across control cats and cats with CKD stages 1/2 and 3/4. They reported decreases in VEGFA, FTL, and NCOA4 with advancing disease, alongside increases in ALOX5 and HIF1A. Advanced CKD samples were enriched mainly for immune and inflammatory terms, while markers tied to GPX4 and ferroptosis were not stage-significant. The authors’ bottom line was not a clean ferroptosis signal, but a more heterogeneous pattern of transcript-level remodeling that still fits with inflammatory and lipid-oxygenation stress in diseased feline kidneys. That doesn’t directly validate the Nottingham lipid findings, but it does make the broader biologic theme more coherent. (mdpi.com)

For practicing veterinarians, the immediate takeaway is not a new test or treatment, but a stronger biologic rationale for why feline kidneys may behave differently from canine kidneys and from kidneys in other mammals. That could eventually influence screening strategies, nutritional conversations, and research priorities. It also reinforces the value of early monitoring in senior cats, since current guidance already emphasizes regular health checks, blood pressure assessment, biochemistry, and urinalysis in older patients, well before obvious clinical decline. (pubmed.ncbi.nlm.nih.gov)

There’s also a client communication angle. Pet parents often ask why CKD is so common in cats despite attentive care and commercial diets. This study doesn’t offer a simple answer, but it does support the idea that part of the risk may be species biology rather than management alone. At the same time, the newer gut-metabolite and transcriptomic data suggest feline CKD is not just a passive wear-and-tear process; it may involve interconnected changes in metabolism, inflammation, microbial activity, and renal stress responses. That distinction can help frame realistic expectations while still leaving room for prevention-focused discussions around nutrition, monitoring, and earlier workups. (nottingham.ac.uk)

What to watch: Expect follow-up work to focus on mechanism and translation: whether these lipid signatures can predict disease before conventional markers rise, whether they differ by diet or life stage, and whether targeted nutritional interventions can reduce lipid accumulation and alter CKD risk over time. It will also be worth watching whether renal lipid findings converge with other emerging biomarkers, especially 2PY and related gut-metabolite signals, and whether inflammatory, hypoxia-response, or lipid-oxygenation gene patterns help identify which cats are on a path toward clinically significant CKD. (nottingham.ac.uk)